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Abstract Nine isotopomers of tryptamine and its halogen
derivatives, labeled with deuterium, tritium in side chain,
i.e., [(1R)-2H]-, [(1R)-3H]-, 5-F-[(1R)-2H]-, 5-F-[(1R)-3H]-,
5-Br-[(1R)-2H]-, double labeled [(1R)-2H/3H]-, 5-F-
[(1R)-2H/3H]-, and ring labeled [4-2H]-, and [5-2H]-trypt-
amine, were obtained by enzymatic decarboxylation of
L-Trp and its appropriate derivatives in deuteriated or tri-
tiated media, respectively. Intermediates: [50-2H]-L-Trp
used for further decarboxylation was synthesized by
enzymatic coupling of [5-2H]-indole with S-methyl-L-cys-
teine, and [40-2H]-L-Trp was obtained by isotope exchange
1H/2H of the authentic L-Trp dissolved in heavy water
induced by UV-irradiation. Doubly labeled [(1R)-2H/3H]-
and 5-F-[(1R)-2H/3H]-tryptamine were obtain by decar-
boxylation of L-Trp or [50-F]-L-Trp carried out in 2H3HO
incubation medium.
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Introduction
Tryptamine, a biogenic amine is also the backbone for a
group of compounds known collectively as tryptamines.
This group includes many biologically active, natural or
synthetic compounds, including neurotransmitters, e.g.,
serotonin, melatonin [1, 2] and psychedelic drugs such as
DMT (N,N-dimethyltryptamine) [3, 4], and psilocybin.
Diversity of tryptamine derivatives due to the large number
of substituents in the different positions of the indole ring
and the aliphatic chain, therefore, this class of compounds
has been widely used in medicinal chemistry for produc-
tion the psychoactive drugs. The tryptamines have a
multiple applications: they regulate many biologically
processes, affect the nervous system (serotonin) [5], and
are involved in the sleep-wake cycle (melatonin) [2].
In mammals brain tryptamine, acting as an endogenous
neurotransmitter, is synthesized by the enzymatic decar-
boxylation of L-tryptophan (L-Trp) catalyzed by aromatic
L-amino acid decarboxylase [AADC (EC 4.1.1.28)], and is
metabolized to 3-indolcetaldehyde (3-IAL) by oxidative
deamination catalyzed by the enzyme monoamine oxidase
(MAO, EC 1.4.3.4) [6] (Fig. 1).
In the plants and mammalian the bioamines, products of
enzymatic decarboxylation of amino acids play a role of
precursors of a wide range of alkaloids and other biologically
active compounds [7]. The enzyme aromatic L-ADDC (EC
4.1.1.28), involved in production of tryptamine [8] is also an
effective catalyst in the decarboxylation of various aromatic
L-amino acids 3,4-dihydroxy-L-phenylalanine (L-DOPA),
L-tryptophan, 50-hydroxy-L-tryptophan, phenyl-L-alanine,
L-tyrosine, and L-histidine [9]. This pyridoxal phosphate
(PLP) containing enzyme is widely distributed in mamma-
lian tissues and is responsible for the production of indol-
amines (serotonin, melatonin), and catecholamines
(dopamine, adrenaline, and noradrenaline) [10]. The enzyme
AADC is found in serum of various animals such as guinea
pig, rat, monkey, mice and humans. Catecholaminergic and
serotonergic cells such as adrenal glands, brain, and other
tissues as liver and kidney are rich in this enzyme [11].
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From a biological point of view the halogen derivatives
of tryptamine are not important for metabolism, neverthe-
less, in many molecules of biological importance hydrogen
can be easy replaced by a halogen, without much changing
the activity of these species. The introducing of 18F, 79Br,
81Br, and 131I in the place of hydrogen atom is widely used
for production of radiopharmaceuticals for nuclear medi-
cine and positron emission tomography (PET) [12]. For
nuclear medicine it is essential to investigate the metabo-
lism of halogen substituted derivatives of biologically
active compounds. Therefore, 18F-tryptamine as the
potential radiopharmaceuticals [13], is a promising agent
for monitoring of abnormal brain states occurring in Par-
kinson and Alzheimer diseases and schizophrenia, should
be a subject of such research.
The studies on the inactive compounds allow to deter-
mine the involving of halogenated tryptamines in meta-
bolic reactions. The object of our further study was an
investigation whether enzyme AADC effectively catalyzes
the oxidative deamination of halogenated derivatives of
tryptamine presented in Fig. 1. For study some intrinsic
details of mechanism of enzymatic oxidative deamination
of halogenated tryptamine and its halogenated derivatives
we are going to use the kinetic (KIE) and solvent isotope
effects (SIE) methods [14–16].
In this work we presented the enzymatic methods of
decarboxylation of L-Trp and its halogenated derivatives
for producing tryptamine and its halogen derivatives spe-
cifically labeled with deuterium and tritium needed to KIE
and SIE studies. The decarboxylation carried out in deu-
teriated or tritiated incubation media was used to synthesis
of isotopomers labeled in the aliphatic chain, i.e.,
[(1R)-2H]-, [(1R)-3H]-, [(1R)-2H/3H]-, 5-F-[(1R)-2H]-, 5-F-
[(1R)-3H], 5-F-[(1R)-2H/3H]-, 5-Br-[(1R)-2H]-tryptamine,




Deuteriated water (99.9 % 2H), 83 % 2H3PO4/
2H2O and
30 % KO2H/2H2O were purchased from Polatom (Poland).
Tritiated water (5 Ci/mL) was from Pharmaceutical Inc.,
Irvine, CA, USA. The enzyme: L-phenylalanine decar-
boxylase (EC 4.1.1.53) from Streptococcus faecalis, and
coenzyme PLP (pyridoxal-50-phosphate) were from Sigma-
Aldrich. The chemicals, needed for trial experiments and
the enzymatic synthesis, such as L-tryptophan, 50-fluoro-L-
tryptophan, 50-bromo-L-tryptophan and all other chemicals
were from Sigma-Aldrich. TLC plates (DC-Alufolien
Kieselgel 60) and silica gel for column chromatography
(Kieselgel 60, 0.063–0.200 mm) were from Merck. Liquid
scintillation cocktail for aqueous samples was from Ratis-
zint eco plus (Germany).
Methods
The 1H NMR spectra were recorded in 2H2O using tetra-
methylsilane, TMS, as internal standard on a Varian












Fig. 1 The metabolic pathway























Derivatives or isotopomers of -Trp
5-F-[(1R)-2H]-tryptamine        X= F, Y= H, Z(R) = 2H
5-F-[(1R)-3H]-tryptamine,       X= F, Y= H, Z(R) = 3H
5-F-[(1R)-2H/3H]-tryptamine, X= F, Y= H, Z(R) = 2H/3H
5-Br-[(1R)-2H]-tryptamine,     X= Br, Y= H, Z(R) = 2H
[(1R)]-2H]-tryptamine             X= H, Y= H, Z (R) = 2H
[(1R)]-3H]-tryptamine,            X= H, Y= H, Z( R) = 3H
[(1R)]-2H/3H]-tryptamine,      X= H, Y= H, Z(R) = 2H/3H
[4-2H]-tryptamine,                 X= H, Y= 2H, Z = H
[5-2H]-tryptamine,                 X= 2H, Y= H, Z = H
Fig. 2 Enzymatic method of
synthesis of isotopologues of
tryptamine and its derivatives
catalyzed by L-phenylalanine
decarboxylase (EC 4.1.1.53)
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identification of substrates and products in the samples
taken in the course of enzymatic reactions. As a developing
solvent the water solution of acetonitrile was used (aceto-
nitrile:water; 4:1, v/v). Radioactivity of samples were
measured using a liquid scintillation counter Perkin Elmer
Tri-Carb 2910TR.
Synthesis
Synthesis of [(1R)-2H]-tryptamine, 1
1. The isotopologue [(1R)-2H]-tryptamine was obtained
by one step reaction by enzymatic decarboxylation of
L-tryptophan in fully deuteriated incubation medium.
The reaction was carried out in an encapped vial with
50 mg (245 lmol) L-Trp sample dissolved in 15 mL of
deuteriated 50 mM Tris–DCl buffer (pD 5.9) to which
4 mg (16 lmol) of PLP and 50 mg (1 U) of enzyme
L-phenylalanine decarboxylase (EC 4.1.1.53) were
added. The reaction mixture was incubated at 37 C
for 2 days and progress of decarboxylation was mon-
itored by TLC. The reaction was quenched by adjust-
ing incubation medium to pH [12 with 30 %
KO2H/2H2O. The enzyme was removed by centrifu-
gation, the volume of post-reaction mixture was
reduced to c. a. 2 mL by evaporation under reduced
pressure at 40 C, loaded on silica gel column
(100 9 10 mm), 1 was eluted with acetonitrile solu-
tion (CH3CN:H2O; 5:1, v/v), and collected as 1.5 mL
fractions. The presence of 1 in the collected fractions
was checked by TLC. The fractions containing 1 were
combined and evaporated under reduced pressure at
40 C and dried under vacuum. As a result 31.7 mg
(196 lmol) sample of [(1R)-2H]-tryptamine was
obtained with 80 % chem. yield. The extent of deu-
terium incorporation (near 100 %) at the (1R) position
of tryptamine was determined by 1H NMR.
Synthesis of [(1R-)3H]-tryptamine, 2
2. The 2 was obtained by decarboxylation of L-Trp car-
ried out similarly as in case of 1 using ten times
reduced amounts of reagents [1 mL of 50 mM Tris–
HCl buffer (pH 5.5), 5 mg (24.5 lmol) of L-Trp,
0.8 mg (3.2 lmol) of PLP, and 5 mg (0.05 U) of
L-phenylalanine decarboxylase]. To this reaction mix-
ture 200 lL of tritiated water (total activity of 5.7 GBq)
was added. After 2 days the reaction was quenched by
changing pH [12 by adding 30 % KOH. The enzyme
was centrifuged off and the mixture was lyophilized
three times to remove the excess of tritiated water. The
residue was dissolved in 200 lL of water and loaded on
to silica gel column (100 9 10 mm). Product 2
was eluted with acetonitrile solution (CH3CN: H2O;
5:1, v/v) and collected as 1.5 mL fractions. From each
fraction 10 lL samples was taken for radioassay. The
fractions containing radioactive 2 were combined,
lyophilized and dried under vacuum. As a results a
sample of 3.1 mg (19.1 lmol) of 2 (78 % chem. yield)
was obtained with a total activity of 3.7 9 104 Bq
(specific activity of 1.49 MBq/mmol).
Synthesis of [(1R)-2H/3H]-tryptamine, 3
3. This isotopomer, doubly labeled with deuterium and
tritium was obtained using the same procedure and
amounts of reagents as in the case of 2 [(1R)-3H]-
tryptamine. The decarboxylation of 5 mg (24.5 lmol)
L-Trp was carried out in fully deuteriated 50 mM Tris–
DCl buffer (pD 5.9) to which 200 lL of 2H3HO with
total activity 5.7 GB was added. As a result 3 mg
(18.6 lmol) of doubly labeled [(1R)-2H/3H]-trypt-
amine was obtained with a total activity of 3 kBq
(specific activity of 1.28 9 105 Bq/mmol) and 76 %
chem. yield.
Synthesis of 5-Br-[(1R)-2H]- tryptamine, 4
4. The sample of 50-bromo-D, L-Trp (50 mg, 176.5 lmol)
was dissolved in 11 mL of deuteriated 50 mM Tris–
DCl buffer (pD 5.9) to which 2 mg (8 lmol) of PLP
and 26.5 mg (1 U) L-phenylalanine decarboxylase
were added. The reaction mixture was incubated at
37 C for 2 days. The separation and purification of
product were the same as in case of isotopomer 1.
Finally, a 7.1 mg (29.7 lmol) sample of 4 was
obtained (14.2 % chem. yield). The extent of deute-
rium incorporation (near 100 %) at the (1R) position of
4 was determined by 1H NMR spectrum.
Synthesis of 5-F-[(1R)-2H]-tryptamine, 5
5. The experimental procedure was similar as in the case
of 1. The sample of 50-fluoro-L-Trp (25 mg, 112 lmol)
was dissolved in 7 mL of deuteriated 50 mM Tris–DCl
buffer (pD 5.9) to which 1 mg (4 lmol) of PLP and
26.5 mg (1 U) of L-phenylalanine decarboxylase were
added. As a result a 18 mg (101 lmol) sample of 5
was obtained with 90 % chem. yield. The extent of
deuterium incorporation (near 100 %) at the (1R)
position of 5 was determined by 1H NMR spectrum.
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Synthesis of 5-F-[(1R)-3H]-tryptamine, 6
6. The 5.8 mg (26.1 lmol) sample of [50-F]-L-Trp was
dissolved in 1.2 mL of 50 mM Tris–HCl buffer (pH 5.5)
to which 0.6 mg (2.43 lmol) of PLP and 5.2 mg (1 U) of
enzyme L-phenylalanine decarboxylase were added. To
this incubation medium 300 lL of tritiated water (total
activity of 8.6 GBq) was introduced. The method of
separation and purification of product was the same as in
the case of 2. As the results 3.9 mg (21.8 lmol) of 6 was
obtained (84 % chem. yield) with total activity
3.1 9 104 Bq (specific activity of 1.24 MBq/mmol).
Synthesis of 5-F-[(1R)-2H/3H]-tryptamine, 7
7. This product was obtained in the same manner as
described in the case of 3. The sample of 5.5 mg
(24.7 lmol) [50-F]-L-Trp was dissolved in 1.4 mL of
50 mM Tris–DCl buffer, pD 5.9, to which 0.6 mg
(2.43 lmol) of PLP, 5.2 mg (1 U) of L-phenylalanine
decarboxylase, and 350 lL of 2H3HO (total activity of
10 GBq) were added. Finally, a 3.6 mg (20.3 lmol)
sample of 7 was afforded (82 % chem. yield) with
total activity 8.7 9 104 Bq (specific activity of
3.56 MBq/mmol).
Synthesis of [4-2H]-tryptamine, 8
8. The sample of 10 mg (48.8 lmol) of [40-2H]-L-Trp,
obtained as described earlier [17] was dissolved in 1 mL
50 mM Tris–HCl buffer (pH 5.5) to which 2 mg
(8 lmol) of PLP and 10 mg (1 U) of L-phenylalanine
decarboxylase were added. The experimental protocol of
synthesis, separation, and purification of 8 was the same
as described for derivative 1. As a result a 6.4 mg
(39.8 lmol) sample of 8 was obtained with 82 % chem.
yield and 73 % of deuterium enrichment at the 40-indole
ring position determined by 1H NMR.
Synthesis of [5-2H]-tryptamine, 9
9. The compound 9 was obtained by the same protocol as in
case of 8 using as a substrate [50-2H]-L-Trp synthesized
according modified procedures described earlier [18].
The sample of 3 mg (14.6 lmol) of [50-2H]-L-Trp
(100 % 2H enrichment) was dissolved in 50 mM Tris–
HCl buffer pH 5.5 to which 0.6 mg (2.43 lmol) of PLP
and 5.2 mg (1 U) L-phenylalanine decarboxylase were
added. As a result a 1.8 mg (11.4 lmol) of 9 was
obtained (78 % chem. yield) with 100 % of deuterium
enrichment.
Results and discussion
Generally, all nine isotopomers of tryptamine and its hal-
ogen derivatives were synthesized in course of enzymatic
decarboxylation, Fig. 1, of appropriate derivatives of
L-tryptophan. For this reaction instead of the enzyme aro-
matic L-ADDC (EC 4.1.1.28) L-phenylalanine decarbox-
ylase (EC 4.1.1.53) from Streptococcus faecalis [14]
(having the similar properties as ADDC) was used. Previ-
ous studies [19, 20] has strongly documented that enzy-
matic decarboxylation of a-L-amino acids undergoes
together with the replacement of carboxyl group by solvent
proton (deuteron/triton) with retention of configuration at
the a-carbon (Fig. 3).
Therefore, the enzymatic decarboxylation of appropri-
ated derivative of L-Trp carried out in fully deuteriated or
tritiated medium produces corresponding tryptamine
labeled with deuterium or tritium in configuration (1R).
Introduction of one deuterium (or tritium) atom from
incubation medium to the newly generated tryptamine and
preserving the configuration at the carbon atom in the a-
position leads to obtain R-isotopologues of tryptamines
[19–22].
The tritium labeled compounds 2 and 6, i.e., [(1R)-3H]-,
and 5-F-[(1R)-3H]- tryptamine were synthesized by enzy-
matic decarboxylation of L-Trp and [50-F]-L-Trp carried out
in tritiated (1H3HO) Tris–HCl buffered medium, pH 5.5 (at
this pH value the enzyme L-phenylalanine decarboxylase
shows the maximum activity). The deuteriated compounds
1, 4, and 5, i.e., [(1R)-2H]-, 5-Br-[(1R)-2H]- and 5-F-
[(1R)-2H]-tryptamine were obtained by decarboxylation of
L-Trp, [50-Br]-D, L-Trp, and [50-F]-L-Trp, respectively, in
fully deuteriated Tris–DCl buffer, pD 5.9. The compounds
3 and 7 doubly labeled with deuterium and tritium, i.e.,
[(1R)-2H/3H]- and 5-F-[(1R)-2H/3H]-tryptamine were syn-
thesized in fully deuteriated Tris–DCl buffer, pD 5.9, to
which tritiated water was added. In the case when the
synthesis was carried out in fully deuteriated incubation
medium its pD was corrected to 5.9 value due to higher pK
(D2O) [23]. In the case of deuteriated media all substrates
for decarboxylation reaction were dissolved in almost
entirely deuteriated 50 mM Tris–DCl buffer (394 mg,
2.5 mmol) of Tris–HCl were dissolved in 50 mL of D2O;
and calculated fraction of H?/D? ions in this way prepared








Fig. 3 The stereochemistry of the enzymatic decarboxylation of
a-amino acids
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The compound 8, i.e., [4-2H]-tryptamine, labeled with
deuterium in the 4-position of indole ring was synthesized
by decarboxylation of [40-2H]-L-Trp which was obtained by
1H/2H isotope exchange according the procedure described
earlier [24, 25]. The exchange was catalyzed with UV light
produced by a 250 W mercury lamp. The sample of L-Trp
dissolved in 2H2O was irradiated in a sealed and outgassed
glass ampoule. The 1H NMR spectrum showed that deu-
terium enrichment at the 40 position of L-Trp was around
73 %.
The indole ring labeled compound 9, i.e. [5-2H]-trypt-
amine was obtained by decarboxylation of [50-2H]-L-Trp
synthesized according earlier described procedures [18,
25]. This intermediate [50-2H]-L-Trp was obtained in two
step synthesis: first 5-bromoindole was reduced by sodium
borodeuteride, NaB2H4, to[5-
2H]-indole [25], which in
next step, catalyzed by enzyme tryptophanase (L-trypto-
phan indole-lyase EC 4.1.99.1), was coupled with S-
methyl-L-cysteine giving [50-2H]-L-Trp [18] (Near 100 %
deuterium incorporation in the 50-position by 1H NMR
spectrum). The enzymatic decarboxylations of [40-2H]-,
and [50-2H]-L-Trp, leading to 8 and 9 were carried out in
50 mM Tris–HCl buffer, pH 5.5.
The derivative 4, i.e. 5-Br-[(1R)-2H]-tryptamine was
obtained with relatively low chemical yield (about 15 %)
as for decarboxylation reaction. It is possible that, this
enzyme is less effective catalyst for decarboxylation of [50-
Br]-L-Trp with such large ring substituent as bromine. For
this reason, we made no attempts to synthesize its isoto-
pologue, i.e. tritiated 5-Br-[(1R)-3H]-tryptamine.
The extent of deuterium incorporation in the (1R)-
position of tryptamines was determined by measuring the
signal integration derived from the a-protons in 1H NMR
spectrum. In the same manner the deuterium enrichment
in the 40- and 50-positions of intermediates [40-2H]-, and
[50-2H]-L-Trp was identified.
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